July 20 (Reuters) - Rubber products maker Ansell Ltd (ANN) announced writedowns and restructuring on Thursday following the sale of its flagship condoms business two months ago.
Ansell said it will spend US$70 million to $100 million over three years to reorganise its supply chain, merge its single-use and medical divisions into a "healthcare" unit and find other cost savings.
It also announced non-cash asset write downs of $20 million to $30 million related to the closure of some "smaller, less efficient" production lines.
Ansell in May sold its oldest division, which produced condoms, for $600 million to China's Humanwell Healthcare Group Co Ltd <600079.SS> and CITIC Capital China Partners LP.
($1 = 1.2566 Australian dollars)
-
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$33.97 |
Change
-0.210(0.61%) |
Mkt cap ! $4.957B | |||
| Open | High | Low | Value | Volume |
| $34.32 | $34.53 | $33.95 | $9.210M | 270.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 465 | $33.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $34.07 | 2023 | 3 |
View Market Depth
| Last trade - 16.10pm 10/09/2025 (20 minute delay) ? |
| ANN (ASX) Chart |